eribulin mesylate

Generic: eribulin mesylate

Labeler: bluepoint laboratories
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name eribulin mesylate
Generic Name eribulin mesylate
Labeler bluepoint laboratories
Dosage Form SOLUTION
Routes
INTRAVENOUS
Active Ingredients

eribulin mesylate .5 mg/mL

Manufacturer
BluePoint Laboratories

Identifiers & Regulatory

Product NDC 68001-656
Product ID 68001-656_3d6bf27d-c44b-598c-e063-6394a90aab53
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA214850
Listing Expiration 2026-12-31
Marketing Start 2025-09-15

Pharmacologic Class

Classes
microtubule inhibition [pe] microtubule inhibitor [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 68001656
Hyphenated Format 68001-656

Supplemental Identifiers

RxCUI
1045456
UNII
AV9U0660CW

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name eribulin mesylate (source: ndc)
Generic Name eribulin mesylate (source: ndc)
Application Number ANDA214850 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • .5 mg/mL
source: ndc
Packaging
  • 1 VIAL, SINGLE-DOSE in 1 CARTON (68001-656-41) / 2 mL in 1 VIAL, SINGLE-DOSE
source: ndc

Packages (1)

Ingredients (1)

eribulin mesylate (.5 mg/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "3d6bf27d-c44b-598c-e063-6394a90aab53", "openfda": {"unii": ["AV9U0660CW"], "rxcui": ["1045456"], "spl_set_id": ["1a1a9cff-d5da-4232-b98f-26f55208dfc4"], "manufacturer_name": ["BluePoint Laboratories"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (68001-656-41)  / 2 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "68001-656-41", "marketing_start_date": "20250915"}], "brand_name": "Eribulin Mesylate", "product_id": "68001-656_3d6bf27d-c44b-598c-e063-6394a90aab53", "dosage_form": "SOLUTION", "pharm_class": ["Microtubule Inhibition [PE]", "Microtubule Inhibitor [EPC]"], "product_ndc": "68001-656", "generic_name": "Eribulin Mesylate", "labeler_name": "BluePoint Laboratories", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Eribulin Mesylate", "active_ingredients": [{"name": "ERIBULIN MESYLATE", "strength": ".5 mg/mL"}], "application_number": "ANDA214850", "marketing_category": "ANDA", "marketing_start_date": "20250915", "listing_expiration_date": "20261231"}